Metraipolis › archive › dc_7f2874d97005

Pathological Complete Response to Nivolumab Plus Ipilimumab Combination Therapy in Advanced Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus — Europe PMC PMID:42254992

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42254992
DOI
10.1002/iju5.70200
License (as archived)
solo-consultazione
Archived
2026-11-01T13:10:40.878Z
SHA-256 of the archived text
dd7cbc9c8f9bf5da3cb3e940baa19c2076458662ab088425ada33f467178a0d0
Stable URL of this page
https://metraipolis.com/documento/dc_7f2874d97005

How to cite

Pathological Complete Response to Nivolumab Plus Ipilimumab Combination Therapy in Advanced Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus — Europe PMC PMID:42254992 — Europe PMC (en), https://europepmc.org/article/MED/42254992 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7f2874d97005 (Metraipolis archive dc_7f2874d97005, sha256 dd7cbc9c8f9bf5da3cb3e940baa19c2076458662ab088425ada33f467178a0d0)
BibTeX
@misc{dc7f2874d97005,
  title = {Pathological Complete Response to Nivolumab Plus Ipilimumab Combination Therapy in Advanced Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus — Europe PMC PMID:42254992},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42254992},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7f2874d97005; sha256 dd7cbc9c8f9bf5da3cb3e940baa19c2076458662ab088425ada33f467178a0d0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42254992. Agents can read the archived copy with the MCP tool read_document.